I am a medical oncologist who specializes in treating patients with blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome. I received my doctor of medicine from the Washington University School of Medicine in St. Louis and completed my fellowship in hematology and oncology right here at The Ohio State University.
My primary research focus is on myeloid malignancies, specifically working to better understand how leukemia develops and how leukemia cells respond to novel targeted therapies. I’m very passionate about seeing discoveries from this research translated into improved treatment options for leukemia patients at The James and around the world.
In addition to my clinical work and research, I serve as an assistant professor in the Division of Hematology, Department of Internal Medicine at Ohio State. I am also a member of several professional organizations, including the American Society of Clinical Oncology, the American Society of Hematology and the American College of Physicians.
I am honored to be a part of the OSUCCC – James. The close collaboration between everyone in the hospital is truly unique, and it’s rewarding both personally and professionally to be able to work alongside a diverse team of smart, hardworking clinicians and researchers who are focused on improving the lives of leukemia patients and achieving our ultimate goal of a cancer-free world.
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. Grieselhuber has reported no relationships with companies or entities.